Skip to main navigation Skip to search Skip to main content

MRC IAA (Internal) Further development and characterisation of a bispecific nanobody to GPVI and human serum albumin as a novel anti-thrombotic therapy

Project Details

Short titleMRC IAA (Internal) Further development and characterisation of a bispecific nanobody to GPVI and human serum albumin as a novel anti-thrombotic therapy
StatusActive
Effective start/end date1/03/25 → 28/02/27

Funding

  • Medical Research Council